Publication:
Different profiles of advanced heart failure among patients with and without diabetes mellitus. Findings from the EPICTER study.

dc.contributor.authorLorido, José Carlos Arévalo
dc.contributor.authorGómez, Juana Carretero
dc.contributor.authorCorrea, Miriam Romero
dc.contributor.authorIglesias, Jesus Recio
dc.contributor.authorFernández, Teresa Choucino
dc.contributor.authorCamajuncosa, Rosa Jordana
dc.contributor.authorIzquierdo, Margarita Carrera
dc.contributor.authorGuardiola, Carlos Jiménez
dc.contributor.authorPardo, Lucía Fuentes
dc.contributor.authorRuiz, Esther Piniella
dc.contributor.authorFormiga, Francesc
dc.contributor.authorBautista, Prado Salamanca
dc.date.accessioned2023-05-03T14:56:21Z
dc.date.available2023-05-03T14:56:21Z
dc.date.issued2022-07-22
dc.description.abstractThis work aims to compare the characteristics of advanced heart failure (HF) in patients with and without type 2 diabetes mellitus (DM) and to determine the relevance of variables used to define advanced HF. This cross-sectional, multicenter study included patients hospitalized for HF. They were classified into four groups according to presence/absence of advanced HF, determined based on general and cardiac criteria, and presence/absence of DM. To analyze the importance of variables, we grew a random forest algorithm (RF) based on mortality at six months. A total of 3153 patients were included. The prevalence of advanced HF among patients with DM was 24% compared to 23% among those without DM (p=0.53). Patients with advanced HF and DM had more comorbidity related to cardiovascular and renal diseases; their prognosis was the poorest (log-rank <0.0001) though the adjusted hazard ratio by group in the Cox regression analysis was not significant. The variables that were significantly related to mortality were the number of comorbidities (p=0.005) and systolic blood pressure (p=0.024). The RF showed that general criteria were more important for defining advanced HF than cardiac criteria. Patients with advanced HF and DM were characterized by DM in progression with macro and microvascular complications. The outcomes among advanced HF patients were poor; patients with advanced HF and DM had the poorest outcomes. General criteria were the most important to establish accurately a definition of advanced HF, being decisive the evidence of disease progression in patients with DM.
dc.identifier.doi10.1016/j.ejim.2022.07.014
dc.identifier.essn1879-0828
dc.identifier.pmid35879216
dc.identifier.urihttp://hdl.handle.net/10668/22183
dc.journal.titleEuropean journal of internal medicine
dc.journal.titleabbreviationEur J Intern Med
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria Norte de Huelva
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.organizationAGS - Norte de Huelva
dc.page.number59-65
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.subjectAdvanced heart failure
dc.subjectDiabetes Mellitus
dc.subjectDiabetes complications
dc.subjectPalliative care
dc.subject.meshComorbidity
dc.subject.meshCross-Sectional Studies
dc.subject.meshDiabetes Mellitus
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshHeart Failure
dc.subject.meshHospitalization
dc.subject.meshHumans
dc.titleDifferent profiles of advanced heart failure among patients with and without diabetes mellitus. Findings from the EPICTER study.
dc.typeresearch article
dc.volume.number104
dspace.entity.typePublication

Files